SEC 13F Intelligence

Cloverfields Capital Group, LP / NVSN

Cloverfields Capital Group, LP’s Novartis AG Position

Does Cloverfields Capital Group, LP own Novartis AG (NVSN)? Yes — 22.9K shares worth $3M (+1.13% of its 13F portfolio) as of Q1 2026, down from 23.7K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
22.9K
% of Portfolio
+1.13%
Quarters Held
9
currently held

Position History NVSN

Reported value by quarter
Q4 ’22: $561,194Q4 ’22Q1 ’23: $577,944Q3 ’24: $2MQ3 ’24Q4 ’24: $2MQ1 ’25: $2MQ1 ’25Q2 ’25: $2MQ3 ’25: $2MQ3 ’25Q4 ’25: $3MQ1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202622.9K$3M+1.13%
Q4 202523.7K$3M+1.01%
Q3 202518.6K$2M+0.75%
Q2 202520.5K$2M+0.74%
Q1 202519.3K$2M+0.71%
Q4 202419.4K$2M+0.61%
Q3 202418.2K$2M+0.68%
Q1 20236.3K$577,944+0.19%
Q4 20226.2K$561,194+0.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cloverfields Capital Group, LP’s full portfolio or all institutional holders of NVSN.